The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Abstract
In patients with diabetes, an increased risk of symptomatic heart failure usually develops in the presence of hypertension or ischemic heart disease. However, a predisposition to heart failure might also reflect the effects of underlying abnormalities in diastolic function that can occur in asymptomatic patients with diabetes alone (termed diabetic cardiomyopathy). Evidence of cardiomyopathy has also been demonstrated in animal models of both Type 1 (streptozotocin-induced diabetes) and Type 2 diabetes (Zucker diabetic fatty rats and ob/ob or db/db mice). During insulin resistance or diabetes, the heart rapidly modifies its energy metabolism, resulting in augmented fatty acid and decreased glucose consumption. Accumulating evidence suggests that this alteration of cardiac metabolism plays an important role in the development of cardiomyopathy. Hence, a better understanding of this dysregulation in cardiac substrate utilization during insulin resistance and diabetes could provide information as to potential targets for the treatment of cardiomyopathy. This review is focused on evaluating the acute and chronic regulation and dysregulation of cardiac metabolism in normal and insulin-resistant/diabetic hearts and how these changes could contribute toward the development of cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–272 of 272
Hue, L., Beauloye, C., Marsin, A.-S., Bertrand, L., Horman, S., & Rider, M. H. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2063 · Cited by 107
Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis
Galvez, A. S., Ulloa, J. A., Chiong, M., Criollo, A., Eisner, V., Barros, L. F., & Lavandero, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211824200 · Cited by 107
Vetter, R., Rehfeld, U., Reißfelder, C., Weiß, W., Wagner, K., Günther, J., Hammes, A., Tschöpe, C., DILLMANN, W. H., & Paul, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-1019fje · Cited by 106
Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements
Armoni, M., Harel, C., Bar‐Yoseph, F., Milo, S., & Karnieli, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502740200 · Cited by 102
Sakamoto, J., Barr, R. L., Kavanagh, K. M., & Lopaschuk, G. D. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1196 · Cited by 102
Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity
Derave, W., Hansen, B. F., Lund, S., Kristiansen, S., & Richter, E. A. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e947 · Cited by 102
Apolipoprotein B Production Reduces Lipotoxic Cardiomyopathy
Yokoyama, M., Yagyu, H., Hu, Y., Seo, T., Hirata, K., Homma, S., & Goldberg, I. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311995200 · Cited by 101
Influence of metabolic substrate on rat heart function and metabolism at different coronary flows
Burkhoff, D., Weiss, R. G., Schulman, S. P., Filho, R. K., Wannenburg, T., & Gerstenblith, G. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.3.h741 · Cited by 100
Golfman, L. S., Wilson, C. R., Sharma, S., Burgmaier, M., Young, M. E., Guthrie, P. H., Van Arsdall, M., Adrogue, J. V., Brown, K. K., & Taegtmeyer, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2005 · Cited by 99 · cited 1×
“In a different study, changing cardiac metabolic profile by treating ZDF rats with PPAR- agonist also improved contractile function (91).”
BackgroundGha Young, L. E. E., Kim, N. H., Zhao, Z., Soo, B., & Kim, Y. S. (2004) · Biochemical Journal · doi:10.1042/bj20031565 · Cited by 97
The role of oxidative stress in Salt-Induced hypertension
Bayorh, M. A., Ganafa, A. A., Socci, R. R., Silvestrov, N. A., & Abukhalaf, I. K. (2003) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.08.003 · Cited by 96
The metabolic “switch” AMPK regulates cardiac heparin-releasable lipoprotein lipase
An, D., Pulinilkunnil, T., Qi, D., Ghosh, S., Abrahani, A., & Rodrigues, B. B. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00211.2004 · Cited by 96
Self-citationRole of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle.
Jensen, J., Aslesen, R., Ivy, J. L., & Brors, O. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.4.e649 · Cited by 95
Picano, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00647-8 · Cited by 95
Carley, A. N., Semeniuk, L. M., Shimoni, Y., Aasum, E., Larsen, T. S., Berger, J. P., & Severson, D. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2003 · Cited by 94
Jagasia, D. H., Whiting, J. M., Concato, J., Pfau, S. E., & McNulty, P. H. (2001) · Circulation · doi:10.1161/01.cir.103.13.1734 · Cited by 90
Wold, L. E., & Ren, J. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.138 · Cited by 88
Nagao, M., Parimoo, B., & Tanaka, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80500-6 · Cited by 87
DIABETES MELLITUS AND CORONARY HEART DISEASE
Wilson, P. W. F. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70219-x · Cited by 85
Panagia, M., Gibbons, G. F., Radda, G. K., & Clarke, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2004 · Cited by 83
Role of fructose 2,6-bisphosphate in the control of heart glycolysis
Depre, C., Rider, M. H., Veitch, K., & Hue, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38648-x · Cited by 82
Wang, P., & Chatham, J. C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00295.2003 · Cited by 81
Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart
Nicholl, T. A., Lopaschuk, G. D., & McNeill, J. H. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.4.h1053 · Cited by 81
Endothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity
Pillarisetti, S., Paka, L., Sasaki, A., Vanni, T. M., Yin, B., Parthasarathy, N., Wagner, W. D., & Goldberg, I. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15753 · Cited by 80
Differential Effects of Streptozotocin-Induced Diabetes on Cardiac Lipoprotein Lipase Activity
Rodrigues, B. B., Cam, M. C., Jian, K., Lim, F., Sambandam, N., & Shepherd, G. (1997) · Diabetes · doi:10.2337/diab.46.8.1346 · Cited by 79
Self-citationLipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes.
O'Looney, P. A., Irwin, D. J., Briscoe, P., & Vahouny, G. V. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89749-6 · Cited by 78
Montanari, D., Yin, H. H., Dobrzynski, E., Agata, J., Yoshida, H., Chao, J., & Chao, L. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1573 · Cited by 74
Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes
Nuutila, P., Knuuti, J. M., Ruotsalainen, U., Koivisto, V. A., Eronen, E., Teräs, M., Bergman, J. R., Haaparanta‐Solin, M., Voipio-Pulkki, L. M., Viikari, J. S. A., et al. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.5.e756 · Cited by 74
Aldose Reductase and AGE‐RAGE Pathways: Key Players in Myocardial Ischemic Injury
Kaneko, M., Bucciarelli, L. G., Hwang, Y. C., LEE, L., Yan, S. F., Schmidt, A. M., & Ramasamy, R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.081 · Cited by 73
Bertrand, L., Alessi, D. R., Deprez, J., Deák, M., Viaene, E., Rider, M. H., & Hue, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30927 · Cited by 72
Mechanisms underlying depressed Na+/Ca2+ exchanger activity in the diabetic heart
Schaffer, S. W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00020-5 · Cited by 72
Suárez, J., Belke, D. D., Gloss, B. R., Dieterle, T., McDonough, P. M., Kim, Y., Brunton, L. L., & DILLMANN, W. H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00245.2003 · Cited by 71
Khairallah, M., Labarthe, F., Bouchard, B., Danialou, G., Petrof, B. J., & Rosiers, C. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00942.2003 · Cited by 71
Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation
Chatham, J. C., Gao, Z.-P., & Forder, J. R. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.2.e342 · Cited by 71
Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart.
Hidaka, S., Kakuma, T., Yoshimatsu, H., Sakino, H., Fukuchi, S., & Sakata, T. (1999) · Diabetes · doi:10.2337/diabetes.48.2.430 · Cited by 67
Metabolic effects of insulin on cardiomyocytes from control and diabeticdb/dbmouse hearts
Carroll, R., Carley, A. N., Dyck, J. R. B., & Severson, D. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2004 · Cited by 64
Vikramadithyan, R. K., Hirata, K., Yagyu, H., Hu, Y., Augustus, A. S., Homma, S., & Goldberg, I. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080259 · Cited by 63
Transcriptional Regulation of the Human GLUT4 Gene Promoter in Diabetic Transgenic Mice
Olson, A. L., & Pessin, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23491 · Cited by 62
Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart
Lopaschuk, G. D., & Barr, R. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6353-2_15 · Cited by 62
Hasselbaink, D. M., Glatz, J. F. C., Luiken, J. J. F. P., Roemen, T. H. M., & Vusse, G. J. (2003) · Biochemical Journal · doi:10.1042/bj20021617 · Cited by 60
Chatham, J. C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.020974 · Cited by 60
Niu, Y., Hauton, D., & Evans, R. D. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.061473 · Cited by 60
O’Donnell, J. M., Zampino, M., Alpert, N. M., Fasano, M. J., Geenen, D. L., & Lewandowski, E. D. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00139.2005 · Cited by 54
Chatham, J. C. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00056-5 · Cited by 54
Role of dietary fatty acids and acute hyperglycemia in modulating cardiac cell death
Ghosh, S., An, D., Pulinilkunnil, T., Qi, D., Lau, H. C. S., Abrahani, A., Innis, S. M., & Rodrigues, B. B. (2004) · Nutrition · doi:10.1016/j.nut.2004.06.013 · Cited by 53
Self-citationHauton, D., Bennett, M. J., & Evans, R. D. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00146-9 · Cited by 53
Microvascular Perfusion and Transport in the Diabetic Heart
McDonagh, P. F., & Hokama, J. Y. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00118.x · Cited by 53
Relationship between cardiac function and substrate oxidation in hearts of diabetic rats
Chatham, J. C., & Forder, J. R. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.1.h52 · Cited by 53
Measurements of fatty acid and carbohydrate metabolism in te isolated working rat heart
Lopaschuk, G. D., & Barr, R. L. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006875823561 · Cited by 53
Monti, L. D., Landoni, C., Setola, E., Galluccio, E., Lucotti, P., Sandoli, E. P., Origgi, A., Lucignani, G., Piatti, P., & Fazio, F. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00629.2003 · Cited by 52
Pillutla, P., Hwang, Y. C., Augustus, A. S., Yokoyama, M., Yagyu, H., Johnston, T. P., Kaneko, M., Ramasamy, R., & Goldberg, I. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00273.2004 · Cited by 51
Paz, K., Hemi, R., LeRoith, D., Karasik, A., Kanety, H., & Zick, Y. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211820 · Cited by 48
Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats
Lopaschuk, G. D., Saddik, M., Barr, R. L., Huang, L., Barker, C. C., & MUZYKA, R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2006.263.6.e1046 · Cited by 48
Chylomicron and palmitate metabolism by perfused hearts from diabetic mice
Neitzel, A., Carley, A. N., & Severson, D. L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00380.2002 · Cited by 47
Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power
King, K. L., Okere, I. C., Sharma, N., Dyck, J. R. B., Reszko, A. E., McElfresh, T. A., Kerner, J., Chandler, M. P., Lopaschuk, G. D., & Stanley, W. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00210.2005 · Cited by 45
Jensen, J., Ruzzin, J., Jebens, E., Brennesvik, E. O., & Knardahl, S. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01437.x · Cited by 39
Saito, F., Kawaguchi, M., Izumida, J., Asakura, T., Maehara, K., & Maruyama, Y. (2003) · Diabetologia · doi:10.1007/s00125-003-1156-y · Cited by 39
Finck, B. N. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134371.70815.32 · Cited by 38
Diabetes Mellitus and Heart Failure
Jagasia, D., & McNulty, P. H. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00901.x · Cited by 38
Aasum, E., Cooper, M., Severson, D. L., & Larsen, T. S. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-139 · Cited by 37 · cited 1×
“To validate the role of altered metabolism in provoking cardiac dysfunction, several studies have treated 6- or 9-wk-old db/db mice with either PPAR- or PPAR- agonists for 3–6 wk (3, 4, 36).”
MethodSaeki, T., Ohno, T., Kamata, K., Arai, K., Mizuguchi, S., Katori, M., Saigenji, K., & Majima, M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00538.2002 · Cited by 36
Myocardial Metabolism in Type 1 Diabetic Patients Without Coronary Artery Disease
Doria, A., Nosadini, R., Avogaro, A., Fioretto, P., & Crepaldi, G. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb02168.x · Cited by 35
Methodology for measuring in vitro/ex vivo cardiac energy metabolism
Barr, R. L., & Lopaschuk, G. D. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00096-4 · Cited by 34
Depre, C., Veitch, K., & Hue, L. (1993) · PubMed · Cited by 33
Vincent, G., Bouchard, B., Khairallah, M., & Rosiers, C. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00717.2003 · Cited by 33
Diabetes and Heart Disease: An Evidence-Driven Guide to Risk Factors Management in Diabetes
Lteif, A. A., Mather, K. J., & Clark, C. M. (2003) · Cardiology in Review · doi:10.1097/01.crd.0000086892.07437.05 · Cited by 32
Iwasaki, T., Takahashi, S., Takahashi, M., Zenimaru, Y., Kujiraoka, T., Ishihara, M., Nagano, M., Suzuki, J., Miyamori, I., Naiki, H., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0043 · Cited by 32
Cardiac membrane Ca2+-transport in alloxan-induced diabetes in rats
Golfman, L. S., Takeda, N., & Dhalla, N. S. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01233-8 · Cited by 30
Effects of diabetes and hypertension on myocardial Na+-Ca2+ exchange
Kashihara, H., Shi, Z. Q., Yu, J. Z., McNeill, J. H., & Tibbits, G. F. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-78-1-12 · Cited by 29
Measurement of myocardial glycogen synthesis in diabetic and fasted rats
Laughlin, M. R., Petit, W. A., Shulman, R. G., & Barrett, E. J. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e184 · Cited by 29
Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats
Lopaschuk, G. D., Saddik, M., Barr, R. L., Huang, L., Barker, C. C., & MUZYKA, R. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.6.e1046 · Cited by 24
Raev, D. (1994) · Heart and Vessels · doi:10.1007/bf01745237 · Cited by 22
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
The ABC transporter structure and mechanism: perspectives on recent research
Jones, P. M., & George, A. M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3336-9 · Cited by 578
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Gibb, A. A., & Hill, B. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312017 · Cited by 387
Metadata
- Authors
- An, D., & Rodrigues, B.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2006-10
- Volume
- 291
- Issue
- 4
- Pages
- H1489-H1506
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W1972913443
- Cited by
- 446
- References
- 272
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.